Sign in
4

Changes in Ownership

REGENXBIO Inc. Filed Acc 0000899243-16-012448

Options or other derivatives

  • President and CEO acquired 225,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Mills Kenneth T. · President and CEO

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2016-01-28 Grant or award : show line 1 in the form Stock Option (Right to Buy) +225,000 $13.09 2026-01-27 225,000 225,000 D
Loading xslF345X03/doc4.xml…